Effectiveness of Video Monitoring and Care Transition for Heart Failure Patients (EVIT-HF): Randomized Clinical Trial
NCT ID: NCT06731166
Last Updated: 2025-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
500 participants
INTERVENTIONAL
2025-06-01
2028-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer is: Is video monitoring superior to monitoring via audio calls in patients with heart failure?
Researchers will compare monitoring by video to a monitoring by audio to see if drug videomonitoring works to improve selfcare in heart failure and other outocomes.
Participants will:
intervention group receive video calls guided by cardiologist nurses at 7, 30, 60, 180 and 365 days after hospital discharge.
the control group will receive audio calls for data collection, at the same time mentioned.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Remote Patient Monitoring on Heart Failure Management
NCT00778986
Better Effectiveness After Transition - Heart Failure
NCT01360203
Telemonitoring in Patients With Heart Failure
NCT00502255
Determine Return on Investment in Heart Failure Remote Monitoring Program
NCT02475577
Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care
NCT00300261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Videomonitoring Group
Videomonitoring by cardiovascular nursing
self-care
Videomonitoring provide by cardiovascular nurses
Voice call group
Voice call by cardiovascular nurses
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
self-care
Videomonitoring provide by cardiovascular nurses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted for decompensated HFrEF
* Ejection fraction less than 40% confirmed by echocardiogram performed in the last 3 months
* Who access to a mobile device with internet access
Exclusion Criteria
* who had undergone coronary artery bypass in the last 3 months ;
* who were in palliative care;
* who had a life expectancy of less than 1 year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Rio Grande do Sul
OTHER
Universidade Federal do Triangulo Mineiro
OTHER
Federal University of Uberlandia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
OMAR PEREIRA DE ALMEIDA NETO
Head
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
OMAR DE ALMEIDA NETO, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Uberlandia
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ethics committee 5.568.868
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.